These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 30689556)
21. Co-expression Network Analysis Identified COL8A1 Is Associated with the Progression and Prognosis in Human Colon Adenocarcinoma. Shang J; Wang F; Chen P; Wang X; Ding F; Liu S; Zhao Q Dig Dis Sci; 2018 May; 63(5):1219-1228. PubMed ID: 29497907 [TBL] [Abstract][Full Text] [Related]
22. Bladder cancer stage-associated hub genes revealed by WGCNA co-expression network analysis. Di Y; Chen D; Yu W; Yan L Hereditas; 2019; 156():7. PubMed ID: 30723390 [TBL] [Abstract][Full Text] [Related]
23. Identification of hub genes in bladder transitional cell carcinoma through ceRNA network construction integrated with gene network analysis. Wang H; Gao L; Chen Y; Zhang L; Bai Y; Zhao C; Zhang L; Zuo L; Sun H J Cell Mol Med; 2024 Mar; 28(5):e17979. PubMed ID: 37795791 [TBL] [Abstract][Full Text] [Related]
24. LGALS4 as a Prognostic Factor in Urothelial Carcinoma of Bladder Affects Cell Functions. Ding Y; Cao Q; Wang C; Duan H; Shen H Technol Cancer Res Treat; 2019 Jan; 18():1533033819876601. PubMed ID: 31558111 [TBL] [Abstract][Full Text] [Related]
25. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma. Chen P; Wang F; Feng J; Zhou R; Chang Y; Liu J; Zhao Q Oncotarget; 2017 Jul; 8(30):48948-48958. PubMed ID: 28430663 [TBL] [Abstract][Full Text] [Related]
26. Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma. Xu W; Rao Q; An Y; Li M; Zhang Z PLoS One; 2018; 13(8):e0202763. PubMed ID: 30138346 [TBL] [Abstract][Full Text] [Related]
27. Identification of a 13‑mRNA signature for predicting disease progression and prognosis in patients with bladder cancer. Yin H; Zhang C; Gou X; He W; Gan D Oncol Rep; 2020 Feb; 43(2):379-394. PubMed ID: 31894276 [TBL] [Abstract][Full Text] [Related]
28. Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon. Li H; Lin G; Cui M; Wang L; Ding D; Li X; Fan X; Yang Q; Wang Y; Kang C; Zhang L; Liu B; Su J Medicine (Baltimore); 2023 Dec; 102(48):e36414. PubMed ID: 38050320 [TBL] [Abstract][Full Text] [Related]
29. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis. Fang E; Zhang X Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411 [TBL] [Abstract][Full Text] [Related]
30. Gene co-expression network reveals shared modules predictive of stage and grade in serous ovarian cancers. Sun Q; Zhao H; Zhang C; Hu T; Wu J; Lin X; Luo D; Wang C; Meng L; Xi L; Li K; Hu J; Ma D; Zhu T Oncotarget; 2017 Jun; 8(26):42983-42996. PubMed ID: 28562334 [TBL] [Abstract][Full Text] [Related]
31. Integrated weighted gene co-expression network analysis reveals biomarkers associated with prognosis of high-grade serous ovarian cancer. Wang B; Chao S; Guo B J Clin Lab Anal; 2022 Feb; 36(2):e24165. PubMed ID: 34997982 [TBL] [Abstract][Full Text] [Related]
32. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data. Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618 [TBL] [Abstract][Full Text] [Related]
33. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
34. Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer. Zhou Q; Ren J; Hou J; Wang G; Ju L; Xiao Y; Gong Y J Cancer Res Clin Oncol; 2019 Sep; 145(9):2383-2396. PubMed ID: 31280346 [TBL] [Abstract][Full Text] [Related]
36. Identification of Key Genes and Circular RNAs in Human Gastric Cancer. Hao S; Lv J; Yang Q; Wang A; Li Z; Guo Y; Zhang G Med Sci Monit; 2019 Apr; 25():2488-2504. PubMed ID: 30948703 [TBL] [Abstract][Full Text] [Related]
37. Mass spectrometric detection combined with bioinformatic analysis identified possible protein markers and key pathways associated with bladder cancer. Wu Z; Wang S; Jiang F; Li Q; Wang C; Wang H; Zhang W; Xue P; Wang SL Gene; 2017 Aug; 626():407-413. PubMed ID: 28552713 [TBL] [Abstract][Full Text] [Related]
38. Identification of grade-related genes and construction of a robust genomic-clinicopathologic nomogram for predicting recurrence of bladder cancer. Peng X; Wang J; Li D; Chen X; Liu K; Zhang C; Lai Y Medicine (Baltimore); 2020 Nov; 99(47):e23179. PubMed ID: 33217824 [TBL] [Abstract][Full Text] [Related]
39. Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis. Wang Y; Chen L; Ju L; Qian K; Liu X; Wang X; Xiao Y Front Oncol; 2019; 9():1030. PubMed ID: 31681575 [TBL] [Abstract][Full Text] [Related]
40. Potential mechanism of RRM2 for promoting Cervical Cancer based on weighted gene co-expression network analysis. Wang J; Yi Y; Chen Y; Xiong Y; Zhang W Int J Med Sci; 2020; 17(15):2362-2372. PubMed ID: 32922202 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]